Report cover image

Global Human Insulin Market 2025 – 2034

Published Jan 01, 2025
SKU # CSTM20462121

Description

According to Custom Market Insights (CMI), the human insulin market made $56.95 billion in 2025 and is expected to reach $119.47 billion by the end of 2034, with an annual growth rate of 8.58%. As the world has modernized quickly, the number of people with diabetes has grown a lot over time.

Diabetes is now a very common disease that affects people of all ages. Because of this, there is a huge demand for these medicines on the market right now. Because these drugs make the body get used to them, the market sees an increase in demand over time. The market makes a lot of money over time because more and more people are using advanced medicines to better control and manage their diabetes. Diabetes is also very common in kids now, which has made the market for human insulin grow a lot.

You can read the whole report, ""Human Insulin Market Size, Trends and Insights By Type (Modern Human Insulin, Traditional Human Insulin), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Type of Diabetes (Diabetes Type 1, Diabetes Type 2), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034,"" at https://www.custommarketinsights.com/report/human-insulin-market/.

Regional Snapshots

The North American region has emerged as the predominant market for human insulin, characterized by a substantial population of diabetic individuals. The number of people with diabetes has gone up because more people are becoming obese, which is caused by not getting enough exercise and eating unhealthy foods.

The many problems that come with this disease have also made people want more advanced human insulin options. Diabetic patients often use human insulin to quickly control their blood sugar levels and stabilize their condition.

The Asia Pacific region has also seen a huge demand for human insulin because there are so many customers there. The government's provision of modern health care facilities has significantly enhanced the market for human insulin. The Asia Pacific region has seen huge growth in the market for human insulin because there are more and more people in this area who need it.

Changes in the market

Drivers

People who live a sedentary lifestyle are more likely to be overweight and have high cholesterol, which are two of the main causes of diabetes. The market for human insulin has grown because more people want modern medicine and are open to new technology. The introduction of new diabetes medications that work better has increased the demand and sales of insulin on the market. Over time, these things help the market reach new heights.

Limitations

The high cost of insulin and other diabetes medicines has made it hard for the human insulin market to grow. The fact that diabetic medicines can be addictive has slowed the growth of the human insulin market. People who take chemically formatted medicines for a long time have health problems, which makes it hard for the market to grow. These factors have greatly slowed the growth of the market.

Possibilities

The fact that so many people have diabetes is a big chance for the developing market. The number of diabetic patients has gone up a lot because there are more and more old people all over the world. Modern ways of living are a big cause of diabetes because foods and drinks have a lot of sugar and chemicals in them. These reasons have given the most important players in the market great chances.

Problems

The different prices of diabetes medications have made it hard for the market to meet demand and supply. The side effects that come with modern medicine have made it hard for the market to grow. Consumers are having trouble choosing the right medicines because the key players in the market are competing with each other to bring advanced medicines to the market. These many things have made it very hard for the human insulin market to grow.

The report's scope

Part of the Report

More information

The size of the market in 2025

56.95 billion US dollars

Estimated Size of the Market in 2034

USD 119.47 Billion

CAGR Growth Rate

CAGR of 8.58%

The Year of the Base

2024

Time Frame for the Forecast

2025 to 2034

Important Part

By Type, Distribution Channel, Diabetes Type, and Region

What the report covers

Company profile, revenue estimation and forecast, competitive landscape, growth factors, and recent trends

Area of Interest

North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America

Choices for Buying

Ask for personalized buying options that meet your research needs.

Key Points of the Report

The modern human insulin market is huge because more people want modern medicine and more people are willing to use new technologies. Because there are so many cases of diabetes around the world, there is a greater need for modern insulin options that help patients manage their diabetes better and have fewer side effects and complications. Type 1 diabetes is now the most common type of diabetes in the world, especially in North America and the Asia Pacific region.

Type 2 diabetes has been common in European countries. Online pharmacies have grown a lot because more and more people are shopping online, which lets them enjoy all the services without leaving their comfort zone. These facilities help older people become self-sufficient and independent, which is good for them.

Patients can choose from a wide range of medicines at online pharmacies based on their properties, cost, and quality. The hospital pharmacy industry has also grown a lot because so many people go there to manage their diabetes and get regular checkups.

Retail pharmacies have grown a lot because people in the area prefer to avoid the costs of going to the hospital and instead buy medicines directly over the counter based on the prescriptions they got at the hospital. The North American market has grown a lot because there are so many people with diabetes and their disposable income is rising, which means they can buy these advanced medicines.

Table of Contents

Chapter 1. Preface
1.1 Report Description and Scope
1.2 Research scope
1.3 Research methodology
1.3.1 Market Research Type
1.3.2 Market research methodology
Chapter 2. Executive Summary
2.1 Global Human Insulin Market, (2025 - 2034) (USD Billion)
2.2 Global Human Insulin Market: snapshot
Chapter 3. Global Human Insulin Market - Industry Analysis
3.1 Human Insulin Market: Market Dynamics
3.2 Market Drivers
3.2.1 Increasing advancement in technology
3.2.2 the Rapidly increasing number of patients suffering from diabetes
3.3 Market Restraints
3.4 Market Opportunities
3.5 Market Challenges
3.6 Porter’s Five Forces Analysis
3.7 Market Attractiveness Analysis
3.7.1 Market attractiveness analysis By Type
3.7.2 Market attractiveness analysis By Distribution Channel
3.7.3 Market attractiveness analysis By Type of Diabetes
Chapter 4. Global Human Insulin Market- Competitive Landscape
4.1 Company market share analysis
4.1.1 Global Human Insulin Market: company market share, 2025
4.2 Strategic development
4.2.1 Acquisitions & mergers
4.2.2 New Product launches
4.2.3 Agreements, partnerships, cullaborations, and joint ventures
4.2.4 Research and development and Regional expansion
4.3 Price trend analysis
Chapter 5. Global Human Insulin Market - Type Analysis
5.1 Global Human Insulin Market overview: By Type
5.1.1 Global Human Insulin Market share, By Type, 2025 and 2034
5.2 Modern Human Insulin
5.2.1 Global Human Insulin Market by Modern Human Insulin, 2025 - 2034 (USD Billion)
5.3 Traditional Human Insulin
5.3.1 Global Human Insulin Market by Traditional Human Insulin, 2025 - 2034 (USD Billion)
Chapter 6. Global Human Insulin Market - Distribution Channel Analysis
6.1 Global Human Insulin Market overview: By Distribution Channel
6.1.1 Global Human Insulin Market share, By Distribution Channel, 2025 and 2034
6.2 Retail Pharmacies
6.2.1 Global Human Insulin Market by Retail Pharmacies, 2025 - 2034 (USD Billion)
6.3 Hospital Pharmacies
6.3.1 Global Human Insulin Market by Hospital Pharmacies, 2025 - 2034 (USD Billion)
6.4 Online Pharmacies
6.4.1 Global Human Insulin Market by Online Pharmacies, 2025 - 2034 (USD Billion)
Chapter 7. Global Human Insulin Market - Type of Diabetes Analysis
7.1 Global Human Insulin Market overview: By Type of Diabetes
7.1.1 Global Human Insulin Market share, By Type of Diabetes, 2025 and 2034
7.2 Diabetes Type 1
7.2.1 Global Human Insulin Market by Diabetes Type 1, 2025 - 2034 (USD Billion)
7.3 Diabetes Type 2
7.3.1 Global Human Insulin Market by Diabetes Type 2, 2025 - 2034 (USD Billion)
Chapter 8. Human Insulin Market - Regional Analysis
8.1 Global Human Insulin Market Regional Overview
8.2 Global Human Insulin Market Share, by Region, 2025 & 2034 (USD Billion)
8.3. North America
8.3.1 North America Human Insulin Market, 2025 - 2034 (USD Billion)
8.3.1.1 North America Human Insulin Market, by Country, 2025 - 2034 (USD Billion)
8.4 North America Human Insulin Market, by Type, 2025 - 2034
8.4.1 North America Human Insulin Market, by Type, 2025 - 2034 (USD Billion)
8.5 North America Human Insulin Market, by Distribution Channel, 2025 - 2034
8.5.1 North America Human Insulin Market, by Distribution Channel, 2025 - 2034 (USD Billion)
8.6 North America Human Insulin Market, by Type of Diabetes, 2025 - 2034
8.6.1 North America Human Insulin Market, by Type of Diabetes, 2025 - 2034 (USD Billion)
8.4. Europe
8.4.2 Europe Human Insulin Market, 2025 - 2034 (USD Billion)
8.4.2.1 Europe Human Insulin Market, by Country, 2025 - 2034 (USD Billion)
8.4 Europe Human Insulin Market, by Type, 2025 - 2034
8.4.1 Europe Human Insulin Market, by Type, 2025 - 2034 (USD Billion)
8.5 Europe Human Insulin Market, by Distribution Channel, 2025 - 2034
8.5.1 Europe Human Insulin Market, by Distribution Channel, 2025 - 2034 (USD Billion)
8.6 Europe Human Insulin Market, by Type of Diabetes, 2025 - 2034
8.6.1 Europe Human Insulin Market, by Type of Diabetes, 2025 - 2034 (USD Billion)
8.5. Asia Pacific
8.5.3 Asia Pacific Human Insulin Market, 2025 - 2034 (USD Billion)
8.5.3.1 Asia Pacific Human Insulin Market, by Country, 2025 - 2034 (USD Billion)
8.4 Asia Pacific Human Insulin Market, by Type, 2025 - 2034
8.4.1 Asia Pacific Human Insulin Market, by Type, 2025 - 2034 (USD Billion)
8.5 Asia Pacific Human Insulin Market, by Distribution Channel, 2025 - 2034
8.5.1 Asia Pacific Human Insulin Market, by Distribution Channel, 2025 - 2034 (USD Billion)
8.6 Asia Pacific Human Insulin Market, by Type of Diabetes, 2025 - 2034
8.6.1 Asia Pacific Human Insulin Market, by Type of Diabetes, 2025 - 2034 (USD Billion)
8.6. Latin America
8.6.4 Latin America Human Insulin Market, 2025 - 2034 (USD Billion)
8.6.4.1 Latin America Human Insulin Market, by Country, 2025 - 2034 (USD Billion)
8.4 Latin America Human Insulin Market, by Type, 2025 - 2034
8.4.1 Latin America Human Insulin Market, by Type, 2025 - 2034 (USD Billion)
8.5 Latin America Human Insulin Market, by Distribution Channel, 2025 - 2034
8.5.1 Latin America Human Insulin Market, by Distribution Channel, 2025 - 2034 (USD Billion)
8.6 Latin America Human Insulin Market, by Type of Diabetes, 2025 - 2034
8.6.1 Latin America Human Insulin Market, by Type of Diabetes, 2025 - 2034 (USD Billion)
8.7. The Middle-East and Africa
8.7.5 The Middle-East and Africa Human Insulin Market, 2025 - 2034 (USD Billion)
8.7.5.1 The Middle-East and Africa Human Insulin Market, by Country, 2025 - 2034 (USD Billion)
8.4 The Middle-East and Africa Human Insulin Market, by Type, 2025 - 2034
8.4.1 The Middle-East and Africa Human Insulin Market, by Type, 2025 - 2034 (USD Billion)
8.5 The Middle-East and Africa Human Insulin Market, by Distribution Channel, 2025 - 2034
8.5.1 The Middle-East and Africa Human Insulin Market, by Distribution Channel, 2025 - 2034 (USD Billion)
8.6 The Middle-East and Africa Human Insulin Market, by Type of Diabetes, 2025 - 2034
8.6.1 The Middle-East and Africa Human Insulin Market, by Type of Diabetes, 2025 - 2034 (USD Billion)
Chapter 9. Company Profiles
9.1 Novo Nordisk A/S
9.1.1 Overview
9.1.2 Financials
9.1.3 Product Portfolio
9.1.4 Business Strategy
9.1.5 Recent Developments
9.2 Eli Lilly and Company
9.2.1 Overview
9.2.2 Financials
9.2.3 Product Portfolio
9.2.4 Business Strategy
9.2.5 Recent Developments
9.3 Tonghua Dongbao Pharmaceutical Co. Ltd.
9.3.1 Overview
9.3.2 Financials
9.3.3 Product Portfolio
9.3.4 Business Strategy
9.3.5 Recent Developments
9.4 ADOCIA
9.4.1 Overview
9.4.2 Financials
9.4.3 Product Portfolio
9.4.4 Business Strategy
9.4.5 Recent Developments
9.5 Sanofi
9.5.1 Overview
9.5.2 Financials
9.5.3 Product Portfolio
9.5.4 Business Strategy
9.5.5 Recent Developments
9.6 Biocon
9.6.1 Overview
9.6.2 Financials
9.6.3 Product Portfolio
9.6.4 Business Strategy
9.6.5 Recent Developments
9.7 Wockhardt
9.7.1 Overview
9.7.2 Financials
9.7.3 Product Portfolio
9.7.4 Business Strategy
9.7.5 Recent Developments
9.8 Julphar
9.8.1 Overview
9.8.2 Financials
9.8.3 Product Portfolio
9.8.4 Business Strategy
9.8.5 Recent Developments
9.9 Bristol-Myers Squibb Company
9.9.1 Overview
9.9.2 Financials
9.9.3 Product Portfolio
9.9.4 Business Strategy
9.9.5 Recent Developments
9.10 GlaxoSmithKline Plc
9.10.1 Overview
9.10.2 Financials
9.10.3 Product Portfolio
9.10.4 Business Strategy
9.10.5 Recent Developments
9.11 Merck & Co. Inc.
9.11.1 Overview
9.11.2 Financials
9.11.3 Product Portfolio
9.11.4 Business Strategy
9.11.5 Recent Developments
9.12 Pfizer Inc.
9.12.1 Overview
9.12.2 Financials
9.12.3 Product Portfolio
9.12.4 Business Strategy
9.12.5 Recent Developments
9.13 Oramed Pharmaceuticals Inc.
9.13.1 Overview
9.13.2 Financials
9.13.3 Product Portfolio
9.13.4 Business Strategy
9.13.5 Recent Developments
List Of Figures
Figures No 1 to 23
List Of Tables
Tables No 1 to 77
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.